Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Celcuity Inc. - Common Stock (NQ:CELC)

94.19 -1.52 (-1.58%)
Streaming Delayed Price Updated: 3:16 PM EDT, Sep 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 616,802
Open 93.62
Bid (Size) 93.92 (100)
Ask (Size) 94.45 (100)
Prev. Close 95.70
Today's Range 93.38 - 97.43
52wk Range 44.42 - 151.02
Shares Outstanding 46,271,259
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Celcuity (CELC) Q2 2026 Earnings Call Transcript ↗
Revtopik launch underway with 80 oncology specialists supporting expansion into first-line treatment. 
Via The Motley Fool
Topics Earnings
News headline image
Celcuity Q2 Earnings Call Highlights ↗
Celcuity (NASDAQ:CELC) said it remains on track to begin commercial shipments of REVTORPYK, its gedatolisib therapy for certain patients with advanced breast cancer, late in the third quarter of 2026... 
Via MarketBeat
Topics Earnings

Performance

YTD
-6.3%
-6.3%
1 Month
+3.7%
+3.7%
3 Month
+7.7%
+7.7%
6 Month
-17.0%
-17.0%
1 Year
+50.6%
+50.6%

More News

Read More
News headline image
Celcuity Reports Q2 2026 Results: Full Earnings Call Transcript ↗
Via Benzinga
Topics Earnings
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Celcuity Inc. - CELC
From Pomerantz LLP
Via GlobeNewswire
Celcuity Inc. (NASDAQ:CELC) Q1 Earnings Beat Forecasts, But Stock Drops on Phase 3 Data Focus ↗
Via Chartmill
Topics Earnings
News headline image
Bragar Eagel & Squire, P.C. is Investigating Celcuity Inc. on Behalf of Celcuity Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
CELC SHAREHOLDER ALERT: Celcuity Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
From Kirby McInerney LLP
Via Business Wire
News headline image
CELC Investors Have Opportunity to Join Celcuity Inc. Fraud Investigation with SBS Law
From Schall, Brown & Schwartz LLP
Via Business Wire
News headline image
NASDAQ: CELC Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Celcuity Inc. (NASDAQ: CELC) Investors to Contact the Firm
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Celcuity Inc. - CELC
From Pomerantz LLP
Via GlobeNewswire
News headline image
CELCUITY ALERT: Bragar Eagel & Squire, P.C. is Investigating Celcuity Inc. on Behalf of Celcuity Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Celcuity Inc. - CELC
From Pomerantz LLP
Via GlobeNewswire
News headline image
Celcuity Enters Commercial Stage as FDA Approves REVTORPYK for Advanced Breast Cancer ↗
Via MarketBeat
News headline image
QURE Was Just the Beginning: 5 Biotech Catalysts I’m Watching Now ↗
Via InvestorPlace
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill
News headline image
Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Boxer Capital’s $18 Million Corvus Pharma Bet Signals Confidence in This Biotech’s Next Phase ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why One Healthcare Fund Increased Its Kodiak Sciences Stake Amid an Eye-Popping Rally ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Vir Biotechnology Stock Has Doubled This Past Year. One Fund Just Bought 1.2 Million Shares ↗
Via The Motley Fool
News headline image
Celcuity Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Celcuity (CELC) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Structure Therapeutics Stock Is Up 47%, but One Fund Just Fully Exited a $2.6 Million Position ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why One Fund’s $4 Million Alumis Buy Looks Like a Bet on a Breakthrough Autoimmune Drug ↗
Via The Motley Fool
Traders are paying attention to the gapping stocks in Monday's session. ↗
Via Chartmill
Discover the top movers in Monday's pre-market session. ↗
Via Chartmill

Frequently Asked Questions

Is Celcuity Inc. - Common Stock publicly traded?
Yes, Celcuity Inc. - Common Stock is publicly traded.
What exchange does Celcuity Inc. - Common Stock trade on?
Celcuity Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Celcuity Inc. - Common Stock?
The ticker symbol for Celcuity Inc. - Common Stock is CELC on the Nasdaq Stock Market
What is the current price of Celcuity Inc. - Common Stock?
The current price of Celcuity Inc. - Common Stock is 94.19
When was Celcuity Inc. - Common Stock last traded?
The last trade of Celcuity Inc. - Common Stock was at 09/08/26 03:16 PM ET
What is the market capitalization of Celcuity Inc. - Common Stock?
The market capitalization of Celcuity Inc. - Common Stock is 4.36B
How many shares of Celcuity Inc. - Common Stock are outstanding?
Celcuity Inc. - Common Stock has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.